Palle Christophersen - Saniona AB Insider

SANION -- Sweden Stock  

SEK 33.85  1.55  4.38%

Co-Founder and Chief Scientific Officer

Dr. Palle Christophersen, Ph.D. has served as Chief Scientific Officer at Saniona AB since 2014. He is also CoFounder of the Company. He joined NeuroSearch in 1991 as Research Scientist in electrophysiology and served as project manager from 1994, where he developed the NeuroPatch system and discovered Endovion for sickle cell anaemia and cancer. From 20042011, he served as Director of In Vitro Pharmacology, and was in 2006 appointed Vice President and member of the NeuroSearch VP management group. He has authored more than 60 peerreviewed articles and is inventor of more than 60 patents. He is Chief Scientific Officer at Saniona AS. He holds a Doctorate in Philosophy in Physiology from the University of Copenhagen.
Age: 58  Founder Since 2014  Ph.D    
45 70 70 52 25

Management Efficiency

The company has return on total asset (ROA) of (60.0) % which means that it has lost $60.0 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (107.07) % meaning that it generated substantial loss on money invested by shareholders.

Entity Summary

Saniona AB , a research and development company, engages in the discovery and development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. It employs 23 people.Saniona AB (SANION) is traded on Stockholm Stock Exchange in Sweden. It is located in Baltorpvej 154 and employs 23 people.

Saniona AB Leadership Team

Carl Sundberg, Director
Leif Andersson, Director
Anker Lundemose, Director
Claus Braestrup, Chairman, Ph.D
Anna Ljung, Director
Palle Christophersen, Founder, Ph.D
deBethizy, Chairman
Thomas Feldthus, President, MBA
Joergen Drejer, CEO, Ph.D

Stock Performance Indicators

Current Sentiment - SANION

Saniona AB Investor Sentiment
Macroaxis portfolio users are evenly split in their outlook on investing in Saniona AB. What is your outlook on investing in Saniona AB? Are you bullish or bearish?
50% Bullish
50% Bearish

Trending Equities

Currently Active Assets on Macroaxis
Purchased over 100 shares of
few days ago
Traded for 10.44
Purchased over 300 shares of
few days ago
Traded for 6.24
Purchased over 70 shares of
few days ago
Traded for 23.42
Purchased over 200 shares of
few days ago
Traded for 8.1
Purchased over 400 shares of
few days ago
Traded for 4.74
Also please take a look at World Market Map. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.